Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Myelofibrosis presented at the 2026 ASCO Annual Meeting.

VIEW THE TOPICS:

• Investigational Agents and Recent Advances in Therapy in Myelofibrosis
• MOA of JAK Inhibitors and Novel MOAs in Myelofibrosis
• Progressive Disease in Myelofibrosis
• Risk Assessment and Prognosis in Myelofibrosis

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

2026 ASCO Annual Meeting